Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density - PubMed (original) (raw)
Clinical Trial
. 1998 Jul;83(7):2286-90.
doi: 10.1210/jcem.83.7.4964.
Affiliations
- PMID: 9661596
- DOI: 10.1210/jcem.83.7.4964
Clinical Trial
Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density
C J Rosen et al. J Clin Endocrinol Metab. 1998 Jul.
Abstract
We recently demonstrated that insulin growth factor-I (IGF-I) cosegregates with bone mineral density (BMD) in progenitor crosses of two inbred strains of mice. Additionally, we reported that men with idiopathic osteoporosis (IOM) have low serum IGF-I levels, which can be related to BMD and bone turnover. In this study, we considered the possibility that serum IGF-I levels are influenced by molecular genetic variation in the IGF-I structural gene, and that a polymorphic microsatellite (CA repeat) in this locus can be used as a genetic marker for such comparisons. We studied 171 men and women, classified according to the trial in which they were participating. First, in 25 Caucasian men with IOM we noted a very high frequency (64%) of homozygosity for the most common allele (192 bp) in a dinucleotide repeat 1 kb upstream from the transcription start site of the IGF-I gene. This compared with a frequency of only 32% in healthy populations (both men and women) (P < 0.004). Next, we determined that for 116 healthy Caucasian men and women the 192/192 genotype was associated with lower serum IGF-I levels than all other genotypes (192/192: 129 +/- 7 ng/mL vs. others: 154 +/- 7 ng/mL, P = 0.03). We also noted that subjects possessing one 194-bp allele exhibited serum IGF-I levels 25% higher than those homozygous for 192 bp (192/192), (P < 0.005) even after correction for age and sex. Similarly, for men with the 192/192 genotype, serum IGF-I concentrations were lower than any other genotype (145 +/- 10 ng/mL vs. 183 +/- 9 ng/ml P < 0.02). In conclusion, low serum IGF-I levels found in men with IOM are associated with homozygosity for a specific allele of the IGF-I microsatellite (192/192), and individual variation in serum IGF-I levels is influenced by genetic factors and may be specifically influenced by variation at the IGF-I structural locus. Further family and pedigree studies are needed to characterize the relationship of bone mass acquisition to the IGF-I genotype.
Similar articles
- [Decreased bone mineral density and gene polymorphism in primary biliary cirrhosis].
Lakatos PL, Bajnok E, Tornai I, Folhoffer A, Horváth A, Lakatos P, Szalay F. Lakatos PL, et al. Orv Hetil. 2004 Feb 15;145(7):331-6. Orv Hetil. 2004. PMID: 15049048 Hungarian. - Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus.
Takacs I, Koller DL, Peacock M, Christian JC, Hui SL, Conneally PM, Johnston CC Jr, Foroud T, Econs MJ. Takacs I, et al. J Clin Endocrinol Metab. 1999 Dec;84(12):4467-71. doi: 10.1210/jcem.84.12.6179. J Clin Endocrinol Metab. 1999. PMID: 10599704 - The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study.
Rivadeneira F, Houwing-Duistermaat JJ, Beck TJ, Janssen JA, Hofman A, Pols HA, Van Duijn CM, Uitterlinden AG. Rivadeneira F, et al. J Bone Miner Res. 2004 Aug;19(8):1280-90. doi: 10.1359/JBMR.040405. Epub 2004 Apr 12. J Bone Miner Res. 2004. PMID: 15231015 - Nuclear receptor coactivator-3 alleles are associated with serum bioavailable testosterone, insulin-like growth factor-1, and vertebral bone mass in men.
Sheu YT, Zmuda JM, Cauley JA, Moffett SP, Rosen CJ, Ishwad C, Ferrell RE. Sheu YT, et al. J Clin Endocrinol Metab. 2006 Jan;91(1):307-12. doi: 10.1210/jc.2005-0864. Epub 2005 Nov 1. J Clin Endocrinol Metab. 2006. PMID: 16263829 - Insulin-like Growth Factor 1 gene polymorphism and breast cancer risk.
Costa-Silva DR, Barros-Oliveira MD, Borges RS, Tavares CB, Borges US, Alves-Ribeiro FA, Silva VC, Silva BB. Costa-Silva DR, et al. An Acad Bras Cienc. 2016 Oct-Dec;88(4):2349-2356. doi: 10.1590/0001-3765201620160169. Epub 2016 Dec 1. An Acad Bras Cienc. 2016. PMID: 27925035 Review.
Cited by
- IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort.
DeLellis K, Ingles S, Kolonel L, McKean-Cowdin R, Henderson B, Stanczyk F, Probst-Hensch NM. DeLellis K, et al. Br J Cancer. 2003 Jan 27;88(2):277-82. doi: 10.1038/sj.bjc.6600728. Br J Cancer. 2003. PMID: 12610514 Free PMC article. - Genetic Variants in the Insulin-like Growth Factor Pathway and Colorectal Cancer Risk in the Netherlands Cohort Study.
Simons CC, Schouten LJ, Godschalk RW, van Engeland M, van den Brandt PA, van Schooten FJ, Weijenberg MP. Simons CC, et al. Sci Rep. 2015 Sep 18;5:14126. doi: 10.1038/srep14126. Sci Rep. 2015. PMID: 26381944 Free PMC article. - Controversial causal association between IGF family members and osteoporosis: a Mendelian randomization study between UK and FinnGen biobanks.
Tang J, Zhao C, Lin S, Li X, Zhu B, Li Y. Tang J, et al. Front Endocrinol (Lausanne). 2024 Jan 8;14:1332803. doi: 10.3389/fendo.2023.1332803. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260127 Free PMC article. - Genetic modifiers of cancer risk in Lynch syndrome: a review.
Talseth-Palmer BA, Wijnen JT, Grice DM, Scott RJ. Talseth-Palmer BA, et al. Fam Cancer. 2013 Jun;12(2):207-16. doi: 10.1007/s10689-013-9614-2. Fam Cancer. 2013. PMID: 23471748 Free PMC article. Review. - Osteoporosis in men: a review.
Adler RA. Adler RA. Bone Res. 2014 Apr 29;2:14001. doi: 10.1038/boneres.2014.1. eCollection 2014. Bone Res. 2014. PMID: 26273515 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical